The capacity of pluripotent embryonic stem cells (ES cells) to proliferate and differentiate makes them promising tools in the field of cell therapy. In spite of the controversy surrounding the numerous ethical questions raised by this technology, it has been shown to have therapeutic potential for heart, lung, liver, bone and connective tissue regeneration. In addition, a very attractive aspect of this technology is its potential for the treatment of cerebral pathology. A number of studies using ES cell transplants report the differentiation of ES cells in the brain or spinal cord of rodents, and the improvement of locomotor and/or cognitive deficits caused by brain injury. This review offers a synthesis of recent advances in the field of both human and rodent stem cell manipulation to select populations of neurons, astrocytes and oligodendrocytes. In parallel, this review emphasizes the striking similarities that exist between genetically programmed embryonic development of the nervous system and the differentiation of ES cells in vitro. 
mbryonic stem (ES) cells are isolated directly in culture from the inner cell mass (ICM) of pre-implanted embryos (blastocyst) (1, 2) . They are self-renewing, pluripotent and capable of contributing to all the tissues of the embryo in vivo, and into the majority of cell types in vitro, with the exception of extra-embryonic tissue types, at least in the case of mouse ES cells (3) . Interestingly, this differentiation process closely follows a genetic program similar to that turned on during embryonic development. Two principal methods are used for the differentiation of ES cells into neural cells. The first involves the formation of embryoid bodies, within which cells differentiate into the three germ layers and provide morphogenetic signals that are present in the embryo (4) . The second method consists of culturing ES cells in various media conditions to direct neural differentiation and thereby to generate quasi-homogenous populations of neurons or glia.
SELF-RENEWAL OF ES CELLS
ES cells, which represent the very first stem cells of an embryo, are capable of self-renewal, i.e. they can theoretically undergo an infinite number of cell divisions without loss of potential. This process requires the activation of the STAT pathway by either IL-6 or LIF for promoting cell cycle progression and for the maintenance of the undifferentiated state ( Fig. 1 ) (5, 6) . In vitro, the activation of STAT3 by LIF is sufficient for the self-renewal of mouse ES cells. Conversely, in the absence of STAT3 activation by LIF, mouse ES cells differentiate spontaneously (5, 7, 8) . However, LIF exhibits no obvious effects on human ES cell proliferation (9) , suggesting that the role of Stat3 signaling in the self-renewal mechanism may differ between mouse and human ES cells. BMP signaling, involving the interaction of BMP (bone morphogenic proteins) with BMPR1 receptors and the subsequent activation of Smad effectors, also plays a critical role in ES cell selfrenewal. BMPR1 is highly expressed in mouse ES cells but down-regulated when cells differentiate. However BMP action is directly dependent on the presence of LIF in mouse ES cells. In its absence, BMP acts as a strong inducer of mesodermal differentiation while also inhibiting neuronal specification. These interactions between BMP and LIF pathways may occur downstream at the level of CBP/p300 proteins to regulate gene expression (10) .
In addition, two homeodomain transcription factors, NANOG and OCT4, that are highly expressed in the ICM and epiblastic cells of pre-implanted embryos also seem to exert strict control over the self-renewal versus the initiation of the differentiation process of stem cells (11) (12) (13) . Permanent inactivation of the oct4 gene prevents the establishment of pluripotent cell populations, and leads to developmental arrest (13) , whereas stable transfection of OCT4 maintains selfrenewal and pluripotency of human ES cells (14) . However, in culture conditions that induce neurogenesis, the loss of expression of oct4 in ES cells encourages the formation of the endoderm, whereas its overexpression allows neuronal differentiation even in the absence of appropriate culture conditions (15) . Similarly, the constitutive expression of NANOG in ES cells sustains cell potentials, while Nanog deprivation initiates differentiation into endodermal cells (16) . Recent results indi-cate that OCT4 and NANOG act in concert on the proliferation and differentiation of ES cells, by means of molecular mechanisms that are most likely different but whose pathways cross talk (17) .
DIFFERENTIATION OF ES CELLS INTO PRECURSOR CELLS OF THE NEURECTODERM (SPECIFICATION)
Neurectoderm is specified on the dorsal side of the embryonic ectoderm in part due to the inhibition of signaling pathways induced by proteins of the TGFb-family, such as BMP and nodal, by molecules secreted by the dorsal lip of the blastopore, also known as the organizer (18) . Inhibition of BMP signaling along with the level of WNT and FGF signaling allows the neurectoderm to establish a rostro-caudal identity. As demonstrated over the last six decades in Xenopus, BMP4 inhibition by the factors Noggin, Follistatin and Chordin secreted from the organizer, is sufficient to induce neuralization, leading to the concept of the "default model." For instance, neural fate specification can be induced directly from mouse ES cells cultured at low density in the absence of any inducing supplements, suggesting that a default mechanism may prevail in the mouse to direct ES toward a neural stem cell stage (19) . In contrast, expression patterns of BMP and their antagonists do not fit the default model in chick but also in mouse embryos, supporting the idea that other factors and signaling pathways, including FGFs and WNT may also be required for neural induction (for review, 18). Subsequently BMPs are also involved in the establishment of dorso-ventral identity of the neural tube (see section III).
Due to the absence of a three-dimensional structure, ES cells in culture depend upon the addition of factors for efficient neural induction. Experiments show that the neural induction pathway in ES cells is similar to that identified during embryonic development. Undifferentiated human ES cells show high expression levels of nodal and lefty (its own antagonist) and also of SMAD proteins, the downstream effectors of BMP and Nodal signaling pathways (20) . High levels of active SMAD2/3 are correlated with maintenance of human ES cells in a pluripotent state (21) . When differentiation of ES cells is initiated, a decrease in SMAD 2/3 activation and the expression of nodal and lefty is observed (20) . In addition, the WNT signaling pathway interacts with the BMP signaling pathway to regulate the levels of SMAD 2/3 (20) . Interestingly in this context, there is a difference between mouse ES cells and human ES cells. While mouse ES cells maintain pluripotency in the presence of WNT signaling as assessed by the expression of Oct3/4, this effect is not correlated with levels of active SMAD2/3. In contrast, in human ES cells, maintenance of Oct3/4 expression is correlated with active SMAD 2/3 (21).
The results discussed in the preceding paragraph thus suggest that the balance between the induction of cell fates and the maintenance of pluripotency in human ES cells may be due to a conserved reciprocal interaction involving similar signaling pathways. The FGF signaling pathway also intersects with the BMP signaling pathway, and for human ES cells, the addition of FGF-2 helps to maintain the pluripotency of ES cells (22, 23) . However, it is the balance between BMP, 
49R NEURAL DIFFERENTIATION OF ES CELLS
WNT and FGF signaling pathways that determines whether addition of exogenous FGF2 leads to maintenance of human ES cells in an undifferentiated state or whether FGF2 helps in expanding a population of FGF-dependent neural precursor cells.
The organizer secretes antagonists of BMP signaling such as Noggin, Chordin and Follistatin, whose loss reduces specification of ectoderm to neurectoderm. The contextual role of these signaling pathways is highlighted by the fact that ES cells simultaneously produce BMP4 as well as the inhibitors of its own signaling pathway, Noggin and Chordin, at very low concentrations. Therefore either the absence of exogenous BMP4 (24) or overexpression of Noggin or Chordin leads to an increase in the number of differentiated colonies generated from ES cells. A selective inhibition of the WNT pathway in ES cells prevents neural differentiation and enhances the regulated expression of the specific inhibitors of neural differentiation (25) (26) (27) . In parallel, FGF4, by inducing the expression of neuronal markers, appears sufficient but not absolutely necessary for the differentiation of ES cells in culture. While its presence assures the proliferation of differentiating cells, its absence induces neural differentiation (6, 28, 29) . Finally, endogenous retinoic acid (RA) is also required for the establishment of neural specification in embryos, as well as the induction of neural differentiation of embryoid bodies in culture (30) .
To summarize, these results indicate that ES cells undergo specification to generate neural progenitors cells according to mechanisms similar to those that occur during embryonic development in vivo. In particular, inhibitors of BMP4 induce neuralization in concert with supporting factors such as WNT, FGF and RA. The action of BMP is context-dependent as suppression of BMP signaling in floating aggregates of human ES cells leads to induction of neural tissue (31) while in a different context the interaction of these signals gives rise to differentiation of cardiac muscle (32) . The signaling pathways responsible for neural specification are also involved in the acquisition of dorso-ventral identity at a later stage (see next section).
PRONEURAL CELLS DERIVED FROM ES CELLS ACQUIRE BOTH ROSTROCAUDAL AND DORSOVENTRAL IDENTITIES OF STEM CELLS IN THE EMBRYO
Retinoic acid has been identified as a caudalizing factor that, along with FGF and WNT, is important for the neuronal fate of ES cells during the specification of the rostrocaudal axis of the embryonic brain (33, 34) . Further, in ES cells, the addition of RA along with aggregation of cells leads to neural differentiation in a dose-dependent manner (35) . When mouse ES cells are specified to become neural progenitor cells, the phenotype obtained is consistent with RA acting as a caudalizing molecule. Thus the absence of RA results in the appearance of neuronal progenitor cells which express the anterior forebrain markers emx1/2 and nkx2.1, as well as Bf1, a telecenphalic marker (36), while low doses of RA result in the generation of cells that express markers for midbrain neurons (37) . High RA concentrations result in a caudal phenotype with expression of posterior markers such as Hoxc5/6 instead of anterior markers (i.e. Otx2 or En1), and in concert with sonic hedgehog (SHH) signaling, lead to the differentiation of motor neurons (38) . At the level of the anterior neural plate, Wnt signaling exclusion is required for the acquisition of telencephalic characteristics, whereas its activation is required for caudal specification (39) . The inhibition of the FGF signaling pathway suppresses the expression of the RA receptor, and the overexpression of RARa, the RA receptor, restores the effects of FGF, demonstrating the interaction between the RA and FGF pathways in specifying the rostrocaudal neural axis, and suggesting that RARa is a direct target for the FGF signaling pathway (40) .
BMP4 DIFFERENTIATES ES-DERIVED PRONEURAL CELLS INTO NEURONAL PRECURSORS AND NEURAL CREST CELLS (DORSALIZATION)
In the embryo, BMP4 is secreted by the roof plate of the neural tube and forms a dorsal gradient. Depending upon the position of neural precursors along the rostrocaudal axis, the local concentration of BMP-4 specifies the neural phenotype outcomes. Thus in culture conditions (low RA concentrations) that anteriorize the neural precursors, the absence of SHH as a ventralizing factor induces the generation of pallial telencephalic (Pax6 ϩ ) neurons (36) . Furthermore, in serum-free culture conditions compatible with telecenphalic specification (no RA addition and repression of WNT and nodal), Pax6-ϩ cells can be further differentiated into neural retinal precursors (41) . Neural progenitor cells derived from ES cells grown in defined media when exposed to BMP4 will also progressively acquire the characteristics of dorsal neurons and neural crest cells (35) . Thus the presence of BMP4 increases the number of cells expressing markers of the neural crest (including snail, slug and Msx1) while reducing the expression of ventral markers (i.e. nkx2.2 and HNF3␤). In addition, depending upon the dose used, BMP4 induces the differentiation of neural crest precursors into sensory neurons (Brn3a/Peri), or autonomic neurons (TH/Peri). The above results suggest that the role of BMP4 as a dorsalizing factor in the embryo is also observed in ES cells that have been specified to undergo a neural fate. (Fig. 2) .
SHH induces ventral differentiation in proneural cells derived from ES cells to generate motoneurons.
In the mouse embryo, SHH is initially produced by the notochord, and then by the floor plate cells of the neural tube. This peptide diffuses along a concentration gradient in the ventral portion of the neural tube to allow the local differentiation of ventral precursors (18) ; the loss of SHH or the interruption of its signaling pathway results in the dorsalization of the embryo by the expansion of regions under the control of BMP4, leading to a pathology known in humans as holoprosencephaly (42), whereas constitutive expression of SHH triggers a lethal overall outgrowth of embryonic neural tube and suppresses the differentiation of dorsal regions (43) . Gene mutations leading to partial gain of hedgehog functions result in the formation of 50R CAZILLIS ET AL. multiple cancers including medulloblastomas and skin nevoid basal cell carcinomas, also known as Gorlin's syndrome (44) . Several studies have shown that embryoid bodies derived from murine ES cells express two of the three members of the hedgehog family, Indian hedgehog (ihh) as well as Sonic (shh; unpublished data), at the level of the outer visceral endoderm, and direct effectors of its signaling cascade (i.e. patched and gli1) in the inner endoderm (45) . A recent study has shown that along with its role in dorsoventral patterning, SHH is also required for the specification of neurectoderm as well as the responsiveness of ES cells to other neural inducers such as RA (46) . Thus, in the presence of increasing concentrations of SHH, differentiating mouse ES cells expressing markers for the neural crest and for dorsal neurons (Pax7 and Math1) are reduced or disappear, while cells expressing ventral markers (nkx2.2 and HNF3␤) are augmented (35) (Fig. 2) . Mouse embryoid bodies cultured in serum-free medium supplemented with SHH and FGF-8, develop high yields of TuJ1-positive neuroblasts that express either dopaminergic or serotoninergic markers (46) and may represent in vitro models of ventral midbrain-hindbrain neurons.
In mouse ES cells that have been have been cultured on stromal cells to induce neural differentiation, the presence of higher concentrations of SHH results in an increase in the differentiation of neuronal cells expressing ventral markers (nkx2.2 and HNF3␤) along with a decrease in the markers for neural crest and for dorsal neurons (Pax7 and Math1). At a later time during differentiation other markers that identify more specialized populations of cells, such as basal telencephalic motoneurons or brachiomotor and visceral neurons, appear (35, 36) (Fig. 2) . Similar motor neuron phenotypes were also obtained with human ES cells that were "caudalized" by exposure to RA and "ventralized" in the presence of SHH (46) . Finally, SHH signaling, along with FGF8 signaling, leads to the specification and differentiation of dopaminergic neurons. Differentiation of neural progenitors in both mouse and human ES cells into dopaminergic neurons is correlated with the expression of genes such as Nurr1, Lmx1b and Ptx3 that are involved in the patterning and differentiation of dopaminergic neurons during embryonic development (47) . Overexpression of the nuclear receptor Nurr1 has been shown to potentiate the effects of SHH and FGF8 on neuronal differentiation of mouse ES cells (48) . Mouse ES cell lines expressing Nurr1 develop functional characteristics of dopaminergic (DA) neurons after transplantation into the brain of rat models of Parkinson's disease (49) . Similar dopaminergic differentiation has been achieved using human ES cells (50) ; unfortunately, however, these DA-derived human ES cells do not seem to survive and /or retain their dopaminergic phenotype when grafted into rat brain (51) .
DIFFERENTIATION OF GLIA (ASTROCYTES AND OLIGODENDROCYTES
In contrast to the strong interest in neuron generation, in vitro differentiation of ES cells into glia has received very limited attention. During development, gliogenesis occurs at a later time than neurogenesis in the ventral and dorsal zones of the neural tube. This timing is partially controlled by SHH and involves the expression of the transcription factors olig2 and nkx2.2 (52) . Olig2 is alternatively expressed in ventral oligodendrocytic (OL) progenitors or suppressed in neurons and astrocytes. OL fate is reduced or delayed in nkx2.2 or olig2-/-mice, whereas progenitor cells expressing olig2 successfully myelinize axons in culture and in vivo in the injured spinal cord (29, 53) . ES cells can differentially generate glial cell populations including astrocytes, oligodendrocytes and microglia, according to a sequential process whose dynamics resemble that of the mechanisms involved in utero (54, 55) . Thus, olig2-overexpressing ES cells selectively generate oligodendrocytes and motor neurons (56) and FGF2 and SHH act synergistically to induce OL progenitor formation from embryoid bodies (46) (Fig. 2) . The generation of highly-purified olidendrocyte progenitors from mouse ES cells has been recently reported using culture conditions that combined FGF-2, PDGF and T3 supplements (57) .
Neural differentiation of mouse and human ES cells always give rise to a fraction of "contaminating" GFAP-positive cells among the desired populations of neuron or oligodendrocyte progenitors, suggesting that these ES-derived neural stem cell progenitors share the potential to generate both neuronal and glial lineages. However, the differentiation of astrocytes also appears to be under the influence of BMP4 at the level of the dorsal neural tube, suggesting that at least a fraction of astrocytic populations may have an origin distinct from that of ventral OL progenitors. Despite the lack of interest in cell therapy involving ES-derived astrocytes, replenishment may soon become useful as a therapeutic approach in the dramatic case of Alexander's disease, a fatal neurologic illness characterized by white-matter degeneration and the formation of astrocytic cytoplasmic inclusions called Rosenthal fibers, due to mutations in the gene encoding GFAP proteins (58) .
Finally, it is also worth noting here that neural stem cells found in both mouse and human adult brains are characterized by the expression of GFAP, suggesting that they may share common properties with astrocytes (59, 60) .
CONCLUSION
The results discussed above, taken as a whole, demonstrate that the neural differentiation of ES cells in culture progresses according to a genetic program similar to that observed in the embryo. In the absence of a three-dimensional structure, ES cells are a priori capable of giving rise not only to all populations of neurons (motor, sensory and associative) produced in vivo, but also to cells in the oligo-astroglial lineage. The culture of ES cells in the presence of extracellular morphogenetic signals originally identified in embryos as inducers of the positional patterning of specialized cell populations can generate similar cell subtypes, according to a program comparable in certain respects to that occurring in the embryo. In this context, the use of naïve or pre-differentiated ES cells appears to be a definite advance in the treatment of animal models of human neurodegenerative disorders. Using this approach a number of recent studies involving the transplantation of stem cells into the brain of mice exhibiting neuronal 51R NEURAL DIFFERENTIATION OF ES CELLS pathologies similar to human disorders have met with success (49) . However, in the case of leukoencephalopathies, the goal is to generate oligodendrocytes or Schwann cells from ES cells, to myelinate or remyelinate CNS axons on transplantation. While mouse ES cells exhibit this capacity, oligodendrocyte differentiation from human ES cells remains to be optimized before it can be potentially tested in human pathologies (such as Pelizaeus-Merzbacher disease) (61) . One technical limitation that is being rapidly overcome is that most of the human ES cell lines currently used in in vitro studies are contaminated with bovine or murine determinants that are the result of culture conditions, precluding their use in cell therapy. Therefore, new culture protocols based on the use of human feeder cells or artificial three dimensional substrates have recently shown potential to pave the way for human ES cells in cellular therapy (62) .
